NYSE: LLYELI LILLY & Co Stock
$184.49+1.88 (1.03%)
Updated Apr 9, 2021
LLY Price
$184.49
Fair Value Price
N/A
Market Cap
$176.48B
52 Week Low
$129.21
52 Week High
$218.00
P/E
27.05x
P/B
31.28x
P/S
6.25x
PEG
2.01x
Dividend Yield
1.6%
Revenue
$24.54B
Earnings
$6.19B
Gross Margin
77.7%
Operating Margin
29.46%
Profit Margin
25.2%
Debt to Equity
7.23
Operating Cash Flow
$6B
Beta
0.71
Next Earnings
Apr 27, 2021
Ex-Dividend
N/A
Next Dividend
N/A
Zen Score
High
Medium
Low
50
Industry average
Reasons for this score
LLY ($184.49) is trading below its intrinsic value of $414.30, according to Benjamin Graham's Formula from Chapter 11 of "The Intelligent Investor"
Valuation
LLY is poor value based on its earnings relative to its share price (27.05x), compared to the US market average (18.56x)
Valuation
LLY is poor value based on its earnings relative to its share price (27.05x), compared to the US Drug Manufacturers - General industry average (8.49x)
Valuation
LLY News
Valuation
LLY price to earnings (PE)
For valuing profitable companies with steady earnings
Company
27.05x
Industry
8.49x
Market
18.56x
LLY is poor value based on its earnings relative to its share price (27.05x), compared to the US market average (18.56x)
Valuation
LLY is poor value based on its earnings relative to its share price (27.05x), compared to the US Drug Manufacturers - General industry average (8.49x)
Valuation
LLY price to book (PB)
For valuing companies that are loss-making or have lots of physical asset
Company
31.28x
Industry
5.16x
Market
-0.01x
LLY is good value based on its book value relative to its share price (31.28x), compared to the US market average (-0.01x)
Valuation
LLY is poor value based on its book value relative to its share price (31.28x), compared to the US Drug Manufacturers - General industry average (5.16x)
Valuation
LLY price to earnings growth (PEG)
For valuing profitable companies with growth potential
LLY is poor value relative to its rate of earnings growth, measured by PEG ratio (2.01x)
Valuation
LLY's financial health
Profit margin
Revenue
$7.4B
Net Income
$2.1B
Profit Margin
28.5%
LLY's Earnings (EBIT) of $7.23B can safely cover interest payments on company debt ($16.60B)
Financials
LLY's profit margin has decreased (-12.1%) in the last year from (37.3%) to (25.2%)
Financials
Assets to liabilities
Assets
$46.6B
Liabilities
$40.8B
Debt to equity
2.94
LLY's short-term assets ($17.46B) exceed its short-term liabilities ($12.48B)
Financials
LLY's long-term liabilities ($28.33B) exceed its short-term assets ($17.46B)
Financials
LLY's debt has increased relative to shareholder equity (7.23), over the past 5 years ago (1.44)
Financials
LLY's debt to equity ratio (7.23) is considered high
Financials
Cash flow
Operating
$1.8B
Investing
-$674.1M
Financing
-$1.3B
LLY's operating cash flow ($6.50B) is sufficient to service the company's debt ($16.60B)
Financials
ELI LILLY & Stock FAQ
©2021 WallStreetZen
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.